Abstract: An input/output client/server system within a remote control system between general purpose apparatuses provided with TCP/IP compliant communications functions across networks comprising: single or plural general purpose input/output units mounted on the interface boards of remote input/output devices of a general purpose apparatus on the receiver side and provided with a function to give a predetermined response to a command transmitted thereto from a general purpose apparatus on the transmitter side; means for recognizing addresses of the general purpose input/output units provided on the general purpose apparatus on the receiver side; and means for transmitting a command to the general purpose input/output unit by using an IP address of the general purpose apparatus at the destination, an address of the respective interface connected to the respective general purpose input output unit, and the port address of the general purpose input/output unit connected to the general purpose apparatus on the transmitte

Abstract: In a piezoelectric transformer device (36), a plurality of inner electrodes are stacked on each other on the left side. These inner electrodes are alternately connected to each other through interlevel connection conductors to constitute two inner electrode groups. A secondary output electrode in the form of a mesh is formed near the end portion of the device (36) on the right side. Only primary input electrodes (1,2) connected to the two inner electrode groups, a secondary output electrode (40), and the lead electrode of the secondary output electrode in the form of a mesh are exposed on the same surface of the device.

Abstract: Guanidine derivatives of the formula: ##STR1## wherein R.sup.1 is [di(lower)alkylamino](lower)alkyl, morpholinyl(lower)alkyl, lower alkylpiperazinyl or [lower alkylpyrrolidinyl](lower)alkyl,R.sup.2 is halogen, lower alkyl or lower alkoxy, andR.sup.3 is halogen, lower alkyl, lower alkoxy or mono(or di or tri)halo(lower)alkyl,and pharmaceutically acceptable salts thereof which are useful as a medicament.

Abstract: A process for preparing a pharmaceutical composition which comprises admixing a compound of claim 1 or a pharmaceutically acceptable salt thereof with a pharmaceutically acceptable carrier.

Abstract: A bonding defect detecting apparatus is provided for operation in conjunction with an ultrasonic wire bonder using an ultrasonic oscillator driven by a signal. The apparatus has A/D converters for digitally converting a signal waveform of the signal by real-time sampling during a bonding operation. A digital signal processing device is provided for calculating at least one signal characteristic of each of the signal waveforms for each of a plurality of the bonding operation. A data accumulating devices accumulates the at least one signal characteristic for n number of bonding operations of the plurality of the bonding operation. A calculating device calculates an average signal characteristic of the signal characteristics of the n number of bonding operations.

Abstract: Guanidine derivatives of the formula: ##STR1## wherein Y is C--R.sup.1(in which R.sup.1 is hydrogen, lower alkyl, hydroxy, protected hydroxy, etc.,)R.sup.2 is pyrrolyl, tetrazolyl, pyrazolyl, etc.,R.sup.3 is hydrogen, lower alkoxy, hydroxy, protected hydroxy, etc.,Z is C--R.sup.4(in which R.sup.4 is hydrogen, carboxy, protected carboxy, nitro, halogen, hydroxy(lower)alkyl, etc.,), andW is R.sup.12(in which R.sup.12 is hydrogen, lower alkoxy, nitro, hydroxy or protected hydroxy)and pharmaceutically acceptable salts thereof which are useful as a medicament which are useful in inhibiting Na.sup.+ /H.sup.+ exchange in cells and in the prevention of cardiovascular diseases, cerebrovascular diseases, renal diseases, arteriosclerosis and shock.

Abstract: Thiazole compounds of formula ##STR1## are provided which have antiulcer activity and H.sub.2 -receptor antagonism, wherein R.sup.2 is lower alkyl or lower alkoxy(lower)alkyl, R.sup.3 is hydrogen, A is methylene and R.sup.1 is lower alkyl.

Abstract: This invention relates to furylthiazole derivatives represented by the following formula: ##STR1## wherein each symbol is as defined in the specification and pharmaceutically acceptable salts thereof which have antiulcer activity, H.sub.2 -receptor antagonism and antimicrobial activity, to processes for the preparation thereof, to a pharmaceutical composition comprising the same and to a method for the treatment of ulcer and infectious diseases in human being or animals.

Abstract: A compound of the formula: ##STR1## wherein R.sup.1 is amino, acylamino, cyclo(lower)alkenylamino having amino and oxo, imido, triazolylamino, benzoisothiazolylamino, wherein each of said heterocyclicamino groups may be substituted by one or more substituent(s) selected from the group consisting of lower alkyl, amino and oxo, 2-cyano-3-lower alkylguanidino, 2-acyl-3-lower alkylguanidino, 2-acylguanidino, (1-lower alkylamino-2-nitrovinyl)amino, hydroxy, halogen, cyano, acyl, benzimidazolylthio, triazolyl substituted with amino, or a group of the formula: ##STR2## in which R.sup.4 is hydrogen, cyano, or acyl, andR.sup.5 is amino or lower alkoxy,R.sup.2 and R.sup.3 are each hydrogen, acyl or lower alkyl which may have halogen; orR.sup.2 and R.sup.3 are linked together to form lower alkylene,Y is ##STR3## in which R.sup.6 is hydrogen or halogen, andA is lower alkylene, or pharmaceutically acceptable salt thereof.

Abstract: A compound of the formula: ##STR1## wherein R.sup.1 is amino, ureido, lower alkanoylamino, lower alkoxycarbonylamino, lower alkylsulfonylamino, lower alkoxy(lower)alkanoylamino, mono or di or trihalo(lower)alkanoylamino, hydroxy(lower)alkanoylamino, protected hydroxy(lower)alkanoylamino, or a group of the formula: ##STR2## in which R.sup.4 is hydrogen or sulfamoyl, R.sup.5 is amino or lower alkoxy, R.sup.2 is hydrogen, lower alkyl, lower alkoxy(lower)alkyl, di(lower)alkylamino(lower)alkyl, (C.sub.3 -C.sub.7)-cycloalkyl, lower alkenyl or mono or di or trihalo(lower)alkyl; R.sup.3 is hydrogen or lower alkyl; or R.sup.2 and R.sup.3 are linked together to form lower alkylene,Y is ##STR3## in which R.sup.6 is hydrogen, A is lower alkylene, and W is NH; or R.sup.2 -W is piperidino or morpholino, or pharmaceutically acceptable salt thereof.

Abstract: The invention relates to compounds of the formula: ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, A and Q are as described, useful in the treatment of ulcers.

Abstract: A dermatological external agent such as a pharmaceutical, quasi-drug, or cosmetic comprising tetrahydroabietic acid, a salt thereof, and hydrogenated rosin and a salt thereof, formulated therein, has an excellent antibacterial action, is not harmful to the human body, and has an excellent stability.

Abstract: The present invention relates to an deinking agent used for reproduction of printed waste papers such as newspapers, magazines, leaflets and the like, and mainly contains one or more additives selected from the group comprising(a) additives made by adding one or more selected from alkylene oxides to at least one selected from dimer acids and polymer acids of higher unsaturated fatty acids having a carbon number of 16-20;(b) additives made by adding one or more selected from alkylene oxides to at least one selected from partial esters which are made of an alcohol having a carbon number of 1-18 and dimer acids and polymer acids of higher unsaturted fatty acids having a carbon number of 16-20;(c) additives made by adding one or more selected from alkylene oxides to one or more selected from dicarboxylic acids or dicarboxylic acid monoesters.

Abstract: The benzazole compounds of this invention can be represented by the following formula [I]: ##STR1## wherein R.sup.1 is aryl or a heterocyclic group, each of which may have suitable substitutent(s),R.sup.2 is hydroxy, mercapto, lower alkylthio, sulfo, lower alkyl, amino or substituted amino,R.sup.3 is hydrogen, halogen or lower alkoxy,A is lower alkenylene, lower alkylene optionally substituted with hydroxy, or a group of the formula:--A'--Q--A"--,in which A' is lower alkylene, A" is lower alkylene or a single bond, and Q is O or S, andX is O, S, NH or N--R.sup.4, in which R.sup.4 is lower alkyl,More particularly, it relates to benzazole compounds and pharmaceutically acceptable salts thereof which have antiulcer activity and H.sub.2 -receptor antagonism, to processes for the preparation thereof, to a pharmaceutical composition comprising the same and to a method for the treatment of ulcers in human being or animals.

Abstract: The invention relates to cephem compounds of high antimicrobial activity of the formula: ##STR1## wherein R.sup.1 is amino or acylamino,R.sup.2 is lower alkyl, andY is CH or N.

Abstract: This invention relates to the intermediates of formula ##STR1## wherein A.sub.b is hydroxy (lower) alkylene, amino (lower) alkylene, protected amino (lower) alkylene, lower alkenylene, lower alkylene having an oxo group, or hydroxyimino (lower) alkylene wherein the hydrogen atom of the hydroxyimino group may be replaced with a lower aliphatic hydrocarbon group, and R.sup.3 is carboxy or a protected carboxy group, and a salt thereof.

Abstract: This invention relates to a new cephem compound of the formula: ##STR1## wherein R.sup.1 is amino or a substituted amino group;R.sup.2 is carboxy or a protected carboxy group;R.sup.3 is a tetrazolyl group having a lower alkynyl group; andX is --S-- or ##STR2## and pharmaceutically acceptable salts thereof, of high antimicrobial activity.

Abstract: The invention relates to cephem compounds of high antimicrobial activity of the formula: ##STR1## wherein R.sup.1 is amino or acylamino,R.sup.2 is lower alkyl, andY is CH or N.

Abstract: Thiazole intermediates for cepham compounds are described.

Abstract: This invention relates to novel cephem compounds of high antimicrobial activity of the formula ##STR1## wherein R.sup.1 is amino;R.sup.2 is carboxy or a protected carboxy group;A is hydroxy (lower) alkylene, amino (lower) alkylene, protected amino (lower) alkylene, lower alkenylene, hydroxyimino (lower) alkylene, lower alkoxyimino (lower) alkylene, or lower alkenyloxyimino (lower) alkylene; andR.sup.3 is carboxy or a protected carboxy group,and pharmaceutically acceptable salts thereof.